Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Cash from Investing Activities (2020 - 2026)

Surrozen (SRZN) posted quarterly Cash from Investing Activities of -$120000.0 for Q1 2026, down 344.44% year-over-year from $49090.9 in Q1 2025, and down 103.39% quarter-over-quarter from -$59000.0 in Q4 2025.

Analysis

Surrozen (SRZN) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Surrozen's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$120000.0 for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 344.44% year-over-year to -$120000.0; the TTM figure through Mar 2026 stood at -$221000.0 (down 380.43% YoY), while the FY2025 annual figure was -$128000.0, down 392.31% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$120000.0, down from -$59000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $22.8 million in Q3 2022, with the low at -$412000.0 in Q1 2022.
  • The 5-year median for Cash from Investing Activities is -$7000.0 (2024), against an average of $6.0 million.
  • The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities jumped 4305.83% in 2023, then sank 344.44% in 2026.
  • Surrozen's Cash from Investing Activities stood at $1.9 million in 2022, then surged by 396.6% to $9.5 million in 2023, then slumped by 100.2% to -$19000.0 in 2024, then plunged by 210.53% to -$59000.0 in 2025, then plunged by 103.39% to -$120000.0 in 2026.
  • Business Quant data shows SRZN's Cash from Investing Activities at -$120000.0 in Q1 2026, -$59000.0 in Q4 2025, and -$24000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Surrozen 263.35 Mn 263.35 Mn - -19,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19,000.00
Mar 31, 2026 -120,000.00
Dec 31, 2025 -59,000.00
Sep 30, 2025 -24,000.00
Jun 30, 2025 -18,000.00
Mar 31, 2025 -27,000.00
Dec 31, 2024 -19,000.00
Mar 31, 2024 -7,000.00
Dec 31, 2023 9.50 Mn
Sep 30, 2023 7.65 Mn
Jun 30, 2023 17.25 Mn
Mar 31, 2023 17.33 Mn
Dec 31, 2022 1.91 Mn
Sep 30, 2022 22.83 Mn
Jun 30, 2022 13.98 Mn
Mar 31, 2022 -412,000.00
Dec 31, 2021 -16.62 Mn
Sep 30, 2021 -68.29 Mn
Jun 30, 2021 8.64 Mn
Mar 31, 2021 -1.44 Mn